Back to Search
Start Over
Comparison of T 1 Rho MRI, Glucose Metabolism, and Amyloid Burden Across the Cognitive Spectrum: A Pilot Study.
- Source :
-
The Journal of neuropsychiatry and clinical neurosciences [J Neuropsychiatry Clin Neurosci] 2020 Fall; Vol. 32 (4), pp. 352-361. Date of Electronic Publication: 2020 Apr 14. - Publication Year :
- 2020
-
Abstract
- Objective: The pathological cascades associated with the development of Alzheimer's disease (AD) have a common element: acidosis. T <subscript>1</subscript> rho MRI is a pH-sensitive measure, with higher values associated with greater neuropathological burden. The authors investigated the relationship between T <subscript>1</subscript> rho imaging and AD-associated pathologies as determined by available diagnostic imaging techniques.<br />Methods: Twenty-seven participants (men, N=13, women, N=14; ages 55-90) across the cognitive spectrum (healthy control subjects [HCs] with normal cognition, N=17; participants with mild cognitive impairment [MCI], N=7; participants with mild AD, N=3) underwent neuropsychological testing, MRI (T <subscript>1</subscript> -weighted and T <subscript>1</subscript> rho [spin-lattice relaxation time in the rotating frame]), and positron emission tomography imaging ([ <superscript>11</superscript> C]Pittsburg compound B for amyloid burden [N=26] and [ <superscript>18</superscript> F]fluorodeoxyglucose for cerebral glucose metabolism [N=12]). The relationships between global T <subscript>1</subscript> rho values and neuropsychological, demographic, and imaging measures were explored.<br />Results: Global mean and median T <subscript>1</subscript> rho were positively associated with age. After controlling for age, higher global T <subscript>1</subscript> rho was associated with poorer cognitive function, poorer memory function (immediate and delayed memory scores), higher amyloid burden, and more abnormal cerebral glucose metabolism. Regional T <subscript>1</subscript> rho values, when controlling for age, significantly differed between HCs and participants with MCI or AD in select frontal, cingulate, and parietal regions.<br />Conclusions: Higher T <subscript>1</subscript> rho values were associated with greater cognitive impairment and pathological burden. T <subscript>1</subscript> rho, a biomarker that varies according to a feature common to each cascade rather than one that is unique to a particular pathology, has the potential to serve as a metric of neuropathology, theoretically providing a measure for assessing pathological status and for monitoring the neurodegeneration trajectory.
- Subjects :
- Aged
Aged, 80 and over
Aniline Compounds
Female
Fluorodeoxyglucose F18
Humans
Male
Middle Aged
Pilot Projects
Thiazoles
Aging metabolism
Aging pathology
Alzheimer Disease diagnostic imaging
Alzheimer Disease metabolism
Alzheimer Disease pathology
Alzheimer Disease physiopathology
Amyloid beta-Peptides metabolism
Cognitive Dysfunction diagnostic imaging
Cognitive Dysfunction metabolism
Cognitive Dysfunction pathology
Cognitive Dysfunction physiopathology
Glucose metabolism
Magnetic Resonance Imaging standards
Neuroimaging standards
Positron-Emission Tomography standards
Subjects
Details
- Language :
- English
- ISSN :
- 1545-7222
- Volume :
- 32
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- The Journal of neuropsychiatry and clinical neurosciences
- Publication Type :
- Academic Journal
- Accession number :
- 32283991
- Full Text :
- https://doi.org/10.1176/appi.neuropsych.19100221